Evidence map›Paper›PMID 42086584›Full record

ArticleNPJ Parkinson's disease2026

Hippocampal atrophy in untreated de novo Parkinson's disease with obstructive sleep apnea.

Kristína Burdová, Filip Růžička, Josef Mana, Pavel Filip, Jiří Nepožitek, Simona Dostálová, Pavla Peřinová, Ondrej Bezdicek, Petr Gregorovič, Filip Havlík and 4 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kristína Burdová *Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Filip Růžička *Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. filip.ruzicka@vfn.cz.
Josef ManaDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Pavel FilipDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Jiří NepožitekDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Simona DostálováDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Pavla PeřinováDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Ondrej BezdicekDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Petr GregorovičDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Filip HavlíkDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Evžen RůžičkaDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Petr DušekDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Karel ŠonkaDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Robert JechDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. jech@cesnet.cz.

Funding

General University Hospital in Prague project MH CZ-DRO-VFN64165National Institute for Neurological Research - EXCELES ID Project No. LX22NPO5107The Ministry of Health of the Czech Republic (AZV) Grant No. NU21-04-00443The Ministry of Health of the Czech Republic (AZV) Grant No. NU21-04-00443.
6 · The paper itself

Abstract

Over the course of Parkinson's disease (PD), there is considerable intersubject variability in gray matter (GM) loss across a wide range of subcortical structures and cortical areas, which is often predictive of the clinical trajectory of the disease. The biological or clinical factors underlying these individual differences are not well understood. Obstructive sleep apnea (OSA) is a sleep-disordered breathing that is associated with an increased risk of cognitive impairment and neurodegeneration. In this study, we investigated whether moderate-to-severe OSA in untreated de novo PD is linked to more severe GM atrophy compared to PD without OSA and a group of controls. High-resolution structural 3 T MRI T1 and T2-weighted scans were used to estimate subcortical GM volumes and hippocampal subfields, and to perform vertex-wise analyses of cortical thickness and cortical surface area. We found that the presence of OSA was associated with a significant bilateral reduction in hippocampal volume, particularly in the CA1, CA3, and subicular regions, an effect specifically observed in PD patients and not in the control group. These findings suggest that the co-occurrence of OSA and PD may be related to early structural brain changes, highlighting the importance of timely OSA diagnosis and management to potentially delay cognitive decline in PD.

Identifiers

PMID42086584
PMCPMC13346879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.